Annual Operating Expenses
$1.75 M
-$17.68 M-90.98%
01 December 2023
Summary:
Altamira Therapeutics annual total operating expenses is currently $1.75 million, with the most recent change of -$17.68 million (-90.98%) on 01 December 2023. During the last 3 years, it has fallen by -$4.30 million (-71.03%). CYTO annual operating expenses is now -94.39% below its all-time high of $31.24 million, reached on 31 December 2015.CYTO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
N/A
01 June 2024
Summary:
Altamira Therapeutics quarterly total operating expenses is not available.CYTO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTO Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -91.0% | - |
| 3 y3 years | -71.0% | - |
| 5 y5 years | -84.3% | - |
CYTO Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -91.0% | at low | ||
| 5 y | 5 years | -91.0% | at low | ||
| alltime | all time | -94.4% | at low |
Altamira Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $1.75 M(-91.0%) | - |
| Dec 2022 | $19.43 M(+158.5%) | - |
| Dec 2021 | $7.52 M(+24.3%) | - |
| Dec 2020 | $6.05 M(-19.3%) | - |
| Dec 2019 | $7.49 M(-32.7%) | - |
| Dec 2018 | $11.13 M(-55.5%) | $646.40 K(-77.9%) |
| Sept 2018 | - | $2.92 M(-6.4%) |
| June 2018 | - | $3.12 M(-30.9%) |
| Mar 2018 | - | $4.51 M(-19.3%) |
| Dec 2017 | $25.01 M(-15.7%) | $5.59 M(-1.9%) |
| Sept 2017 | - | $5.70 M(-8.6%) |
| June 2017 | - | $6.24 M(-15.8%) |
| Mar 2017 | - | $7.40 M(+50.4%) |
| Dec 2016 | $29.66 M | $4.92 M(-36.9%) |
| Sept 2016 | - | $7.81 M(-15.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $9.19 M(+20.5%) |
| Mar 2016 | - | $7.63 M(+18.7%) |
| Dec 2015 | $31.24 M(+44.5%) | $6.43 M(-13.4%) |
| Sept 2015 | - | $7.42 M(-29.3%) |
| June 2015 | - | $10.51 M(+42.0%) |
| Mar 2015 | - | $7.40 M(+77.4%) |
| Dec 2014 | $21.61 M(+31.2%) | $4.17 M(-30.2%) |
| Sept 2014 | - | $5.98 M(+5.6%) |
| June 2014 | - | $5.66 M(-14.3%) |
| Mar 2014 | - | $6.61 M(+67.3%) |
| Dec 2013 | $16.47 M(+226.1%) | $3.95 M(-20.9%) |
| Sept 2013 | - | $4.99 M(-3.4%) |
| June 2013 | - | $5.17 M(+118.9%) |
| Mar 2013 | - | $2.36 M |
| Dec 2012 | $5.05 M | - |
FAQ
- What is Altamira Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Altamira Therapeutics?
- What is Altamira Therapeutics annual operating expenses year-on-year change?
- What is the all time high quarterly operating expenses for Altamira Therapeutics?
What is Altamira Therapeutics annual total operating expenses?
The current annual operating expenses of CYTO is $1.75 M
What is the all time high annual operating expenses for Altamira Therapeutics?
Altamira Therapeutics all-time high annual total operating expenses is $31.24 M
What is Altamira Therapeutics annual operating expenses year-on-year change?
Over the past year, CYTO annual total operating expenses has changed by -$17.68 M (-90.98%)
What is the all time high quarterly operating expenses for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly total operating expenses is $10.51 M